Panagene Inc Cash Flow Conversion Efficiency

Latest as of September 2025: 0.001x

Panagene Inc cash flow conversion efficiency. Based on the latest financial reports, Panagene Inc (046210) has a cash flow conversion efficiency ratio of 0.001x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩46.17 Million ≈ $31.29K USD) by net assets (₩77.27 Billion ≈ $52.36 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Panagene Inc (2006–2024)

Cash flow conversion efficiency of Panagene Inc from 2006 to 2024. This chart illustrates how Panagene Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Panagene Inc (046210) share price today for real-time trading data and today's change.

Panagene Inc Cash Flow Conversion Ratio Explained

Panagene Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Panagene Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Panagene Inc ranked by their cash flow conversion efficiency. Also see Panagene Inc (046210) total market value for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Aetherium Acquisition Corp NASDAQ:GMFI	N/A
Indo-National Limited NSE:NIPPOBATRY	0.197x
Garda Tujuh Buana Tbk JK:GTBO	-0.014x
Kingston Resources Ltd AU:KSN	0.020x
Implanet SA PA:ALIMP	-0.700x
Plaza Wires Limited NSE:PLAZACABLE	-0.026x
Bookook Steel KO:026940	-0.006x
Chumpower Machinery Corp TWO:4575	0.030x

Annual Cash Flow Conversion Efficiency for Panagene Inc (2006–2024)

The table below shows the annual cash flow conversion efficiency of Panagene Inc from 2006 to 2024. Review 046210 cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩76.04 Billion ≈ $51.53 Million	₩346.54 Million ≈ $234.84K	0.005x	+701.91%
2023-12-31	₩63.57 Billion ≈ $43.08 Million	₩36.13 Million ≈ $24.48K	0.001x	-99.46%
2022-12-31	₩31.69 Billion ≈ $21.48 Million	₩3.36 Billion ≈ $2.28 Million	0.106x	-47.35%
2021-12-31	₩29.84 Billion ≈ $20.22 Million	₩6.01 Billion ≈ $4.07 Million	0.201x	+19.31%
2020-12-31	₩25.07 Billion ≈ $16.99 Million	₩4.23 Billion ≈ $2.87 Million	0.169x	+225.83%
2019-12-31	₩20.20 Billion ≈ $13.69 Million	₩1.05 Billion ≈ $709.60K	0.052x	-17.13%
2018-12-31	₩16.30 Billion ≈ $11.05 Million	₩1.02 Billion ≈ $690.98K	0.063x	+158.64%
2017-12-31	₩19.84 Billion ≈ $13.44 Million	₩-2.12 Billion ≈ $-1.43 Million	-0.107x	-100.63%
2016-12-31	₩21.10 Billion ≈ $14.30 Million	₩-1.12 Billion ≈ $-760.05K	-0.053x	-30.35%
2015-12-31	₩8.91 Billion ≈ $6.04 Million	₩-363.21 Million ≈ $-246.14K	-0.041x	-107.56%
2012-12-31	₩8.92 Billion ≈ $6.05 Million	₩4.81 Billion ≈ $3.26 Million	0.539x	+333.48%
2011-12-31	₩15.94 Billion ≈ $10.80 Million	₩-3.68 Billion ≈ $-2.50 Million	-0.231x	-104.70%
2010-12-31	₩16.66 Billion ≈ $11.29 Million	₩-1.88 Billion ≈ $-1.27 Million	-0.113x	+53.02%
2009-12-31	₩17.92 Billion ≈ $12.15 Million	₩-4.31 Billion ≈ $-2.92 Million	-0.240x	-514.69%
2008-12-31	₩25.88 Billion ≈ $17.54 Million	₩1.50 Billion ≈ $1.02 Million	0.058x	-7.83%
2007-12-31	₩34.14 Billion ≈ $23.14 Million	₩2.15 Billion ≈ $1.45 Million	0.063x	+41.98%
2006-12-31	₩30.94 Billion ≈ $20.97 Million	₩1.37 Billion ≈ $928.01K	0.044x	--

About Panagene Inc

KQ:046210 Korea Biotechnology & Medical Research

Market Cap

$24.89 Million

₩36.73 Billion KRW

Market Cap Rank

#24245 Global

#1719 in Korea

Share Price

₩1143.00

Change (1 day)

-11.87%

52-Week Range

₩999.00 - ₩2650.00

All Time High

₩12000.00